थैलासीमिया

NHS to offer ‘life-changing’ gene therapy for blood disorder thalassaemia

The Guardian - 08 Aug 2024
NHS to offer ‘life-changing’ gene therapy for blood disorder thalassaemia ...

Beta thalassaemia: First gene-editing therapy could cure disorder

BBC.com - 07 Aug 2024
Beta thalassaemia: First gene-editing therapy could cure disorder ...

Cognitive impairment and hippocampal neuronal damage in β-thalassaemia mice

Nature.com - 02 May 2024
Cognitive impairment and hippocampal neuronal damage in β-thalassaemia mice ...

First gene-editing therapy recommended by NICE to treat people with beta thalassaemia

The Pharmaceutical Journal - 08 Aug 2024
First gene-editing therapy recommended by NICE to treat people with beta thalassaemia ...

NHS launches world first gene therapy for thalassaemia patients

Innovation News Network - 09 Aug 2024
NHS launches world first gene therapy for thalassaemia patients ...

VisualAbstract: Deferoxamine, Deferasirox, and Deferiprone Triple Iron Chelator Combination Therapy for β-Thalassaemia

2 Minute Medicine - 06 Nov 2024
VisualAbstract: Deferoxamine, Deferasirox, and Deferiprone Triple Iron Chelator Combination Therapy for β-Thalassaemia ...

Evolution of thalassaemia patients’ survival over the past decades...

ResearchGate - 29 Jun 2024
Evolution of thalassaemia patients’ survival over the past decades... ...

Thalassaemia, TB, asthma drug prices set to rise

The Times of India - 15 Oct 2024
Thalassaemia, TB, asthma drug prices set to rise ...

Global Transfusion Dependent Thalassaemia Management Market Expected to Reach USD 17.91 Million by 2

PharmiWeb.com - 23 Oct 2024
Global Transfusion Dependent Thalassaemia Management Market Expected to Reach USD 17.91 Million by 2 ...

The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression

Wiley Online Library - 30 Jun 2024
The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression ...

NICE recommends Casgevy for treatment of severe beta-thalassaemia

BioNews - 12 Aug 2024
NICE recommends Casgevy for treatment of severe beta-thalassaemia ...

Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis

Frontiers - 22 Apr 2024
Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis ...

NICE issues positive guidance for thalassaemia treatment

Pf Media - 08 Aug 2024
NICE issues positive guidance for thalassaemia treatment ...

New Breakthrough Thalassaemia Treatment - Haemoglobinopathy Coordinating Centre

Manchester University NHS Foundation Trust - 09 Aug 2024
New Breakthrough Thalassaemia Treatment - Haemoglobinopathy Coordinating Centre ...

World Thalassaemia Day 2024: Date, history and significance of the day

Hindustan Times - 08 May 2024
World Thalassaemia Day 2024: Date, history and significance of the day ...

Regional desk review of haemoglobinopathies with an emphasis on thalassaemia and accessibility and availability of safe blood and blood products as per these patients’ requirement in South-East Asia under universal health coverage

World Health Organization - 07 Sep 2021
Regional desk review of haemoglobinopathies with an emphasis on thalassaemia and accessibility and availability of safe blood and blood products as per these patients’ requirement in South-East Asia under universal health coverage ...